Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Baroreflex sensitivity is impaired in essential hypertensives with central obesity

Abstract

Recently, much interest has focussed on the potential interaction between sympathetic nervous system and global cardiovascular risk. We investigated how baroreflex sensitivity (BRS), an index of autonomic function, interacts with central obesity (CO) in an essential hypertensive (EH) population. We selected 170 EHs and 43 normotensives (NT), (median age 47.3±11.3 and 49.1±13 years, respectively). Anthropometric parameters were measured for each and BRS was evaluated by a non-invasive method using Portapres TNO. The BRS evaluation was made using the sequences method. Systolic blood pressure (SBP) and heart rate were significantly higher in EH (P<0.001 and P=0.007, respectively). BRS was significantly greater in NT (P=0.02), and was associated inversely with waist circumference (WC) (P=0.005), but not with SBP or with other metabolic risk factors. Body mass index, total and high-density lipoprotein cholesterol, age and WC were not significantly different between the two groups. These results were confirmed by age pounded analysis. Finally, a separate analysis of the hypertensive group with CO (n=84) demonstrated a significantly lower BRS compared with the other hypertensive patients (n=86) (P<0.001). BRS is associated with WC but not with arterial pressure values and metabolic risk factors. Hypertensive subjects with CO show an impairment of BRS. Owing to its association with abdominal fat distribution and subsequently insulin resistance, BRS could represent a further and reliable index for evaluation of global cardiovascular risk in hypertensive patients.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Lantelme P, Khettab F, Custaud MA, Rial MO, Joanny C, Gharib C et al. Spontaneous baroreflex sensitivity: toward an ideal index of cardiovascular risk in hypertension? J Hypertens 2002; 20: 935–944.

    Article  CAS  Google Scholar 

  2. La Rovere MT, Bigger Jr JT, Marcus F, Mortara A, Schwartz P . Baroreflex sensitivity and heart rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet 1998; 351: 478–484.

    Article  CAS  Google Scholar 

  3. Reaven GM . Banting lecture. 1988 role of insulin resistance in human disease. Diabetes 1988; 37: 1595–1607.

    Article  CAS  Google Scholar 

  4. Guidelines Committee. 2003 European Society of Hypertension – European Society of Cardiology Guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011–1053.

    Article  Google Scholar 

  5. Després JP, Lemieux I, Prud’homme D . Treatment of obesity: need to focus on high risk abdominally obese patients. BMJ 2001; 322: 716–720.

    Article  Google Scholar 

  6. Reaven GM, Lithell H, Landsberg L . Hypertension and associated metabolic abnormalities – the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996; 334: 374–381.

    Article  CAS  Google Scholar 

  7. Alvarez GE, Beske SD, Ballard TP, Davy KP . Sympathetic neural activation in visceral obesity. Circulation 2002; 106 (20): 2533–2536.

    Article  Google Scholar 

  8. Beske SD, Alvarez GE, Ballard TP, Davy KP . Reduced cardiovagal baroreflex gain in visceral obesity: implications for the metabolic syndrome. Am J Physiol 2002; 282: H630–H635.

    CAS  Google Scholar 

  9. Brook R, Julius S . Autonomic imbalance, hypertension and cardiovascular risk. Am Heart J 2000; 13: 112(S)–121(S).

    CAS  Google Scholar 

  10. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. JAMA 2001; 285: 2846–2897.

  11. International Diabetes Federation. Worldwide definition of the metabolic syndrome. Available at: http://www.idf.org/webdata/docs/IDF_Metasyndrome_definition.pdf. Accessed August 24, 2004.

  12. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al. Diagnosis and management of metabolic syndrome An American Heart Association/National Heart, Lung and Blood Institute Scientific Statement. Circulation 2005; 112: 2735–2752.

    Article  Google Scholar 

  13. WHO-ISH Guidelines Subcommittee. 1999 World Health Organisation-International Society of Hypertension guidelines for the management of hypertension. J Hypertens 1999; 17: 151–183.

    Google Scholar 

  14. Imholz BP, Langewounters GJ, van Montfrans GA, Parati G, van Goudoever J, Wesseling KH . Feasibility of ambulatory, continuous 24 h finger arterial pressure recording. Hypertension 1993; 21: 65–73.

    Article  CAS  Google Scholar 

  15. Milan A, Mulatero P, Williams TA, Carra R, Schiavone D, Martuzzi R et al. Bradykinin B2 receptor gene (−58T/C) polymorphism influences baroreflex sensitivity in never-treated hypertensive patients. J Hypertens 2005; 23: 63–69.

    Article  CAS  Google Scholar 

  16. Hall JE, Brands MW, Smith Jr MJ . Obesity-induced hypertension: renal function and systemic hemodynamics. Hypertension 1993; 22: 292–299.

    Article  CAS  Google Scholar 

  17. Julius S . Sympathetic hyperactivity and coronary risk in hypertension. Hypertension 1993; 21: 886–893.

    Article  CAS  Google Scholar 

  18. Julius S, Valentini M, Palatini P . Overweight and hypertension. A 2-way street? Hypertension 2000; 35: 807–813.

    Article  CAS  Google Scholar 

  19. Valentini M, Julius S, Palatini P, Brook RD, Bard RL, Bisognano JD . Attenuation of hemodynamic, metabolic and energy expenditure responses to isoproterenol in patients with hypertension. J Hypertens 2004; 22: 1999–2006.

    Article  CAS  Google Scholar 

  20. Miller AW, Sims JJ, Canavan A, Hsu T, Ujhelyi MR . Impaired vagal reflex activity in insulin-resistant rats. J Cardiovasc Pharmacol 1999; 33 (5): 698–702.

    Article  CAS  Google Scholar 

  21. Van Vliet BN, Hall JE, Mizelle HL, Montani JP, Smith Jr MJ . Reduced parasympathetic control of heart rate in obese dogs. Am J Physiol 1995; 269 (Part 2): H629–H637.

    CAS  PubMed  Google Scholar 

  22. Grassi G, Dell’Oro R, Facchini A, Quarti Trevano F, Bolla GB, Mancia G . Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives. J Hypertens 2004; 22: 2363–2369.

    Article  CAS  Google Scholar 

  23. Lucini D, Cusumano G, Bellia A, Kozakova M, Di Fede G, Lauro R, et al., for the Linosa Study Group. Is reduced baroreflex gain a component of the metabolic syndrome? Insight from the Linosa Study. J Hypertens 2006; 24 (2): 361–370.

    Article  CAS  Google Scholar 

  24. Wahrenberg H, Hertel K, Leijonhufvud BM, Persson LG, Toft E, Arner P . Use of waist circumference to predict insulin resistance: retrospective study. BMJ 2005; 330: 1363–1364.

    Article  Google Scholar 

  25. Despres JP, Pouliot MC, Moorjani S, Nadeau A, Tremblay A, Lupien PJ et al. Loss of abdominal fat and metabolic response to exercise training in obese women. Am J Physiol 1991; 261 (Part 1): E59–E67.

    Google Scholar 

  26. Straznicky NE, Lambert EA, Lambert GW, Masuo K, Esler MD, Nestel PJ . Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with metabolic syndrome. J Clin Endocrinol Metab 2005; 9: 22–27.

    Google Scholar 

  27. Parati G, Frattola A, Di Rienzo M . Effects of aging on 24 hr dynamic baroreceptor control of heart rate in ambulant subjects. Am J Physiol 1995; 268: H1606–H1612.

    CAS  PubMed  Google Scholar 

  28. Christou DD, Jones PP, Pimentel AE, Seals DR . Increased abdominal to peripheral fat distribution contributes to altered autonomic-circulatory control with human aging. Am J Physiol Heart Circ Physiol 2004; 287: H1530–H1537.

    Article  CAS  Google Scholar 

  29. Julius S . Changing role of autonomic nervous system in hypertension. J Hypertens 1990; 8 (7): S59–S65.

    Article  CAS  Google Scholar 

  30. Mancia G, Mark AL . Arterial baroreflex in hymans. In: Abboud FM, Shepherd JT (eds). Handbook of Physiology, the Cardiovascular System, vol. III. American Society of Physiology: Bethesda, Maryland, 1983, pp 755–793.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S Del Colle.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Del Colle, S., Milan, A., Caserta, M. et al. Baroreflex sensitivity is impaired in essential hypertensives with central obesity. J Hum Hypertens 21, 473–478 (2007). https://doi.org/10.1038/sj.jhh.1002163

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1002163

Keywords

This article is cited by

Search

Quick links